{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:47:02Z","timestamp":1775886422454,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jbspin.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,11,26]],"date-time":"2017-11-26T21:15:52Z","timestamp":1511730952000},"page":"147-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Anti-citrullinated peptides antibodies in systemic sclerosis: Meta-analysis of frequency and meaning"],"prefix":"10.1016","volume":"85","author":[{"given":"Guillaume","family":"Laustriat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeline","family":"Ruyssen-Witrand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Constantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Barnetche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Adoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Cantagrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4293-8596","authenticated-orcid":false,"given":"Yannick","family":"Degbo\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2017.11.006_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.autrev.2016.01.007","article-title":"Systemic sclerosis: an update in 2016","volume":"15","author":"Desbois","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0010","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0015","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","article-title":"Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis","volume":"37","author":"Hamaguchi","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0025","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/annrheumdis-2012-201484","article-title":"Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anti-citrullinated protein\/peptide antibody fine specificity profile","volume":"72","author":"Lundberg","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","article-title":"Anti-CCP antibodies: the past, the present and the future","volume":"7","author":"van Venrooij","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0035","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24827","article-title":"Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0040","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0045","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.2005.044602","article-title":"Radiological hand involvement in systemic sclerosis","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0050","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/acr.21668","article-title":"Ultrasonographic hand features in systemic sclerosis and correlates with clinical, biologic and radiographic findings","volume":"64","author":"Elhai","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-008-8073-2","article-title":"Prevalence of autoantibodies to cyclic citrullinated peptide in patients with rheumatic diseases other than rheumatoid arthritis: a French multicenter study","volume":"34","author":"Fabien","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0060","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/rheumatology\/keu022","article-title":"Clinical usefulness of measuring red blood cell distribution width in patients with systemic sclerosis","volume":"53","author":"Farkas","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0065","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/rheumatology\/kep138","article-title":"Anti-hnRNP and other autoantibodies in systemic sclerosis with joint involvement","volume":"48","author":"Generini","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0070","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10067-006-0313-3","article-title":"Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis","volume":"26","author":"Ingegnoli","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0075","first-page":"20","article-title":"Prevalence of anti-CCP antibodies in systemic sclerosis","volume":"59","author":"Marrone","year":"2007","journal-title":"Reumatismo"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0080","first-page":"542","article-title":"Anti-cyclic citrullinated peptide antibody in systemic sclerosis","volume":"26","author":"Morita","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0085","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10067-011-1930-z","article-title":"Anti-cyclic citrullinated peptide antibodies in scleroderma patients","volume":"31","author":"Polimeni","year":"2012","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10067-007-0656-4","article-title":"A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis","volume":"27","author":"Santiago","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0095","doi-asserted-by":"crossref","first-page":"350","DOI":"10.2298\/SARH1206350S","article-title":"The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis","volume":"140","author":"Stamenkovic","year":"2012","journal-title":"Srp Arh Celok Lek"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0100","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1093\/rheumatology\/keq205","article-title":"Usefulness of anti-cyclic citrullinated peptide antibody and rheumatoid factor to detect rheumatoid arthritis in patients with systemic sclerosis","volume":"49","author":"Ueda-Hayakawa","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0105","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF02686081","article-title":"Increased prevalence of anti-third generation cyclic citrullinated peptide antibodies in patients with rheumatoid arthritis and CREST syndrome","volume":"32","author":"Wu","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0110","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/rheumatology\/kep250","article-title":"Ultrasonographic features of the hand and wrist in systemic sclerosis","volume":"48","author":"Cuomo","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0115","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jbspin.2007.07.017","article-title":"The \u201csclerodermic hand\u201d: a radiological and clinical study","volume":"75","author":"Erre","year":"2008","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0120","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/rheumatology\/kem021","article-title":"Systemic sclerosis-rheumatoid arthritis overlap syndrome: a unique combination of features suggests a distinct genetic, serological and clinical entity","volume":"46","author":"Szucs","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0125","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0130","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0135","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3899\/jrheum.131375","article-title":"Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients","volume":"41","author":"Payet","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0140","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis","volume":"26","author":"Klareskog","year":"2008","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0145","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/ard.2009.111906","article-title":"Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls","volume":"69","author":"Arnett","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0150","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.semarthrit.2011.10.003","article-title":"Arthritis in systemic sclerosis: systematic review of the literature and suggestions for the performance of future clinical trials in systemic sclerosis arthritis","volume":"41","author":"Clements","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0155","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rbr.2014.12.011","article-title":"Overlap between systemic sclerosis and rheumatoid arthritis: a distinct clinical entity?","volume":"56","author":"Horimoto","year":"2016","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0165","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.3899\/jrheum.101248","article-title":"Clinical and serological hallmarks of systemic sclerosis overlap syndromes","volume":"38","author":"Pakozdi","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0170","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1136\/annrheumdis-2014-205428","article-title":"Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA","volume":"74","author":"Hecht","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0175","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/ard.62.2.120","article-title":"Anti-citrullinated protein\/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage","volume":"62","author":"Meyer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0180","doi-asserted-by":"crossref","first-page":"e000066","DOI":"10.1136\/rmdopen-2015-000066","article-title":"ACPA-positive primary Sjogren's syndrome: true primary or rheumatoid arthritis-associated Sjogren's syndrome?","volume":"1","author":"Payet","year":"2015","journal-title":"RMD Open"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0185","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00011-008-8110-x","article-title":"Erosive arthritis in systemic lupus erythematosus is associated with high serum C-reactive protein and anti-cyclic citrullinated peptide antibodies","volume":"57","author":"Amezcua-Guerra","year":"2008","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0190","first-page":"77","article-title":"Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus","volume":"35","author":"Chan","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0195","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3899\/jrheum.090338","article-title":"Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming\/erosive arthritis","volume":"36","author":"Kakumanu","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0200","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jbspin.2008.11.007","article-title":"What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?","volume":"76","author":"Zhao","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1546-0096-9-8","article-title":"Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis","volume":"9","author":"Gilliam","year":"2011","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0210","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1097\/MD.0000000000000523","article-title":"In antisynthetase syndrome, ACPA are associated with severe and erosive arthritis: an overlapping rheumatoid arthritis and antisynthetase syndrome","volume":"94","author":"Meyer","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0215","first-page":"511","article-title":"Antibodies to cyclic citrullinated peptides in psoriatic arthritis","volume":"32","author":"Bogliolo","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0220","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/rheumatology\/kew229","article-title":"Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis","volume":"55","author":"Behrens","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0225","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00296-014-2956-8","article-title":"Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease?","volume":"34","author":"Perez-Alamino","year":"2014","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0230","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/annrheumdis-2012-203160","article-title":"Association of fine specificity and repertoire expansion of anti-citrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease","volume":"73","author":"Giles","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0235","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3899\/jrheum.131341","article-title":"A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anti-citrullinated protein antibody positivity","volume":"41","author":"Zhu","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0240","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.rmed.2012.03.006","article-title":"Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease","volume":"106","author":"Fischer","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.jbspin.2017.11.006_bib0245","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/ars.2007.1897","article-title":"The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis","volume":"10","author":"Bringardner","year":"2008","journal-title":"Antioxid Redox Signal"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17301963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X17301963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T01:58:57Z","timestamp":1719626337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X17301963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1297319X17301963"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.11.006","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-citrullinated peptides antibodies in systemic sclerosis: Meta-analysis of frequency and meaning","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}